 Your new post is loading...
Your new post is loading...
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:16 AM
|
Pancreatic Cancer · Prostate Cancer · Renal cell carcinoma · Skin Cancer · Basal cell carcinoma · Melanoma · Squamous cell cancer · Thyroid Cancer ... Circulating Tumor Cells and Circulating Tumor DNA.
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:15 AM
|
Raritan, NJ (May 24, 2011) – Veridex, LLC today announced the launch of the CELLTRACKS® Circulating Melanoma Cell (CMC) kit, providing research scientists with a fast, convenient and reliable way to capture CMCs for ...
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:15 AM
|
Three-Year Clinical Outcomes from Use of Genous™ Stent in Large, Real-World ...Sacramento BeeGenous is OrbusNeich's patented endothelial progenitor cell (EPC) capture technology that promotes the accelerated natural healing of the vessel wall after...
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:14 AM
|
Biocept Announces Allowance of Key Patent for its Circulating Tumor Cell PlatformPR Newswire (press release)9, 2011 /PRNewswire/ -- Biocept, Inc., a privately-held CLIA-certified laboratory testing company, focused on the detection and analysis of...
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:13 AM
|
Plasma DNA and DNA from circulating tumour cells (CTCs) was extracted from Colon Cancer Patients and hybridized against a reference sample for CGH. We compared genetic abberrations of Plasma DNA against normal ...
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:13 AM
|
Products include the BioFlux™ system for studying cellular interactions, the IonFlux™ system for automated ion channel testing, and the IsoFlux system for circulating tumor cell analysis. Fluxion's systems meet the rigorous ...
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:12 AM
|
Martínez–Sales V et al. – Circulating endothelial cells (CEC), in addition to being elevated in heart failure, correlate with von Willebrand facto levels, providing further support for CEC as markers of endothelial ...
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:11 AM
|
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:10 AM
|
SAN DIEGO, Nov. 15, 2011 /PRNewswire/ -- Biocept, Inc. today reported that its scientists and academic collaborators...
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:09 AM
|
An increase of circulating endothelial cells (CEC) is described in several pathologic conditions that involve vascular injury or instability as myocardial infarction, infectious vasculitis and cancer.
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:08 AM
|
Farideh Bischoff, PhD, Vice President of Translational Research at Biocept, said, “Our posters present data that demonstrates our ability to detect estrogen receptor in CTCs, which can be clinically useful in patients for whom a ...
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:07 AM
|
Objective As the precursor of vascular endothelial cells, the impaired number andfunction of circulating endothelial progenitor cell （EPC） have been hailed as a novelconcept in the pathogenesis of diabetic vascular complications.
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:06 AM
|
Transgenomic and ScreenCell Announce Worldwide Distribution and Collaboration ...Business Wire (press release)...
|
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:16 AM
|
Circulating tumor cells (CTCs) have received a lot of attention from both researchers and clinicians because of their prognostic value for progression-free and overall survival in selected tumor types.
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:15 AM
|
... observed with other multi-targeted antiangiogenic kinase inhibitors (MAKs) and included bone marrow of hypocellularity, hair and skin depigmentation, cartilage dysplasia and lymphoid organ degeneration and necrosis.
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:14 AM
|
European Society for Medical Oncology (CTCs are a good predictor for outcome in metastatic #BreastCancer (except HER2+) (ESMO) http://t.co/cKMitahu #bcsm...)...
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:14 AM
|
Researchers Unravel Biochemical Factor Important In Tumor MetastasisNewswise (press release)According to study corresponding author Shengyu Yang, Ph.D., of Moffitt's Comprehensive Melanoma Research Center and the Department of Tumor Biology, elevated...
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:13 AM
|
CellSearch system advances melanoma diagnosticsModernMedicineThe CellSearch system (Veridex LLC) is an in vitro circulating-tumor-cell test that has shown to be of use in the management and treatment of patients with breast, colorectal and prostate...
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:12 AM
|
Transgenomic: Q3 Results, Plavix Test Launch This WeekSeeking AlphaThe products are used to isolate and collect rare circulating tumor cells (CTCs) from blood.
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:12 AM
|
BackgroundColorectal cancer is one of the most common malignant gastrointestinal diseases in many countries. Curative operation combined with chemotherapy and radiotherapy is the main treatment at present.
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:11 AM
|
PARTⅠ. EVALUATION OF THE DIAGNOSTIC TEST Background and aims: Since traditional RT-PCR technology is at best semiquantitative, it has been difficult to differentiate between baseline level of gene expression in ...
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:10 AM
|
Recent work suggested that dissemination of primary cancer cells to distant sites might be an early event.The biological characteristics and clinical relevance of circulating tumor cells(CTCs) in solid cancer is still not clearly ...
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:09 AM
|
Transgenomic Reports Third Quarter Financial ResultsMarketWatch (press release)...
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:08 AM
|
Uncovering a key player in metastasisMIT NewsThe exact role played by platelets has been unclear, but a new paper from Richard Hynes, the Daniel K.
|
|
Scooped by
Gilbert C FAURE
November 18, 2011 4:06 AM
|
Pancreatic cancer is a devastating malignancy and a leading trouble to the clinical doctor. The most important reason of death is metastasis and recurrence. Although the prognosis of not only advanced and metastatic ...
|
Scoop.it!
